TAG:
laboratory company
JVHL Signs a Contract with UnitedHealth Group
By Robert Michel | From the Volume XIV No. 2 – January 29, 2007 Issue
CEO SUMMARY: When UnitedHealth Group announced its exclusive national contract with Laboratory Corporation of America, Joint Venture Hospital Laboratories (JVHL) saw opportunity. That’s because LabCorp does not have a significant presence in Michigan. JVHL parlayed its statewide network…
January 29, 2007 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XIV No. 2 – January 29, 2007 Issue
To make its laboratory test results available to physicians via cellular telephones and wireless PDAs, Spectrum Laboratory Network of Greensboro, North Carolina, will use the MercuryMD service of Thompson Healthcare . Spectrum sales reps will install MercuryMD on th…
Key Trends Drive Change for Clinical Laboratories
By Robert Michel | From the Volume XIV No. 1 – January 8, 2007 Issue
CEO SUMMARY: Technology plays an ever-growing role in reshaping the organization and operation of clinical laboratories. New technologies figure prominently in THE DARK REPORT’S 2007 list of key trends in the clinical laboratory industry. Technological advances in instr…
RedPath Integrated Pathology Raises $4 Million From Investors
By Robert Michel | From the Volume XIII No. 15 – November 6, 2006 Issue
IN PITTSBURGH, PENNSYLVANIA, RedPath Integrated Pathology, Inc. is in the midst of raising money for expansion. On September 25, 2006, it announced a $4 million equity financing commitment from NewSpring Capital of Philadephia, Pennsylvania. RedPath represents an in…
United Health: Quest Is “Out”–LabCorp Is “In”
By Robert Michel | From the Volume XIII No. 14 – October 16, 2006 Issue
CEOSUMMARY: Effective on January 1, 2007, UnitedHealth Group will have one national contract laboratory. On that date, Laboratory Corporation of America becomes the preferred provider and Quest Diagnostics Incorporated becomes an out-of-network laboratory. With access to 34 million United…
Increased Competition For Hospital Lab Referrals
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
CEO SUMMARY: It’s a buyer’s market for hospital send-out testing because the supply of such tests exceeds demand. To fill excess capacity in their labs, some reference/esoteric lab companies are willing to offer rock-bottom prices to new clients. This situation is also motivating nati…
Buyer of MDS’ Canadian Labs Agrees to Pay C$ 900 Million
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
CANADA’S LARGEST CHAIN OF CLINICAL LABORATORIES will change hands in a deal revealed on September 7, 2006 by Toronto’s The Globe and Mail. MDS Inc. will apparently sell its diagnostics division to Borealis Infrastructure Management Inc., a private equit…
Bio-Reference Enters DNA Sequencing Market
By Robert Michel | From the Volume XIII No. 12 – September 5, 2006 Issue
CEOSUMMARY: Bio-Reference Laboratories has just placed an unexpected bet on the wide-open opportunities in genetic testing. The acquisition of GeneDX brings it a respected team of geneticists, capabilities in full DNA sequencing, and a proven track record in testing for rare and complex h…
Three Ex-UroCor Execs Acquitted in Jury Trial
By Robert Michel | From the Volume XIII No. 10 – July 24, 2006 Issue
CEO SUMMARY: On June 30, 2006,three former executives of UroCor,Inc.,accused by the U.S. Attorney of anti-kickback and securities violations, stood and heard the jury verdict in their case. “Not guilty on all counts,” stated the jury foreman. Thus ended the effort to convict former ex…
Defense Attorneys Discuss Details Of UroCor Jury Trial
By Robert Michel | From the Volume XIII No. 10 – July 24, 2006 Issue
CEO SUMMARY: This was the first criminal case involving anti-kickback violations brought against executives of a public laboratory company. Federal prosecutors charged the defendants with offering inducements to referring physicians in several ways. Defense counsel rebutted the prosecutio…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized